TOP > News Release > list in 2008
News Release

New Release Browse by Year

2008 News Release

RSS
Back Number
2011
2010
2009
2008
2007
2006
2005
Browse by Category
Corporate
R&D
Products
Others
2008.12.25Local(Japan)
Daiichi Sankyo Enters Alliance with The Kitasato Institute
2008.12.19R&D
Prasugrel Receives Positive Opinion from the European Committee for Medicinal Products for Human Use (CHMP)
2008.12.19 Corporate
Ranbaxy Reconstitutes Board of Directors following Strategic Alliance with Japan’s Daiichi Sankyo

Ranbaxy CEO and Managing Director Malvinder Mohan Singh Takes Additional Role as Chairman of the Board
2008.12.19Local(Japan)
Announcement regarding ActHib®(pediatric vaccine for the prevention of infections caused by Haemophilus influenza Type b) launch
2008.12.11Local(Japan)
Daiichi Sankyo Submits Application for Approval of CS-866AZ Antihypertensive Combination Drug in Japan
2008.12.08R&D
NEW PHASE II DATA SHOW SAFETY OF ONCE-DAILY ORAL FACTOR Xa INHIBITOR, DU-176b, COMPARABLE TO WARFARIN IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
2008.11.26 Corporate
DAIICHI SANKYO sets up subsidiary in Ireland
Critical step in European expansion
2008.11.17R&D
Start of Phase III Trial on the Anti-influenza Drug CS-8958
2008.11.17 Corporate
DAIICHI SANKYO Notice concerning Determination of Certain Terms of the Issue Stock Options (Stock Acquisition Rights) as Remuneration
2008.11.13Products
DAIICHI SANKYO EUROPE GmbH announce SEVIKAR® a new fixed dose combination treatment for essential hypertension
2008.11.13Local(Japan)
Daiichi Sankyo's Research Foundation Establishes First Annual Clinical Pharmacology Research Award
2008.11.11R&D
ARQULE AND DAIICHI-SANKYO ENTER INTO STRATEGIC R&D PARTNERSHIP TO PROGRESS NOVEL COMPOUNDS TO TARGET CANCER

Product development agreement focused on ARQ 197, c-Met inhibitor,with discovery collaboration directed toward novel kinase inhibitors;
2008.11.10Local(Japan)
Announcement regarding ActHib(pediatric vaccine for the prevention of infections caused by Haemophilus influenza Type b)launch date
2008.11.07 Corporate
Ranbaxy and Daiichi Sankyo Successfully Complete Landmark Deal
2008.10.31 Corporate
DAIICHI SANKYO to Issue Stock Options (Stock Acquisition Rights) as Remuneration
2008.10.31 Corporate
DAIICHI SANKYO to Dissolve Subsidiaries with Sanofi-aventis
2008.10.23 Corporate
UK Levofloxacin SPC and Underlying Patent Upheld by High Court Patent Court
2008.10.20 Corporate
Daiichi Sankyo and Ranbaxy Move Forward Toward
The Completion of the Landmark Deal
2008.10.17 Corporate
Result of the Open Offer for Shares in Ranbaxy Laboratories Limited
2008.10.17R&D
Daiichi Sankyo and Lilly Respond to Speculation
On Status of Prasugrel New Drug Application
2008.09.30Local(Japan)
Daiichi Sankyo Subsidiary to Close Osaka Plant
2008.09.30Local(Japan)
Announcement regarding ActHib(R)(pediatric vaccine for the prevention of infections caused by Haemophilus influenza Type b)
2008.09.27R&D
FDA Continues to Review Prasugrel New Drug Application
2008.09.24 Corporate
Notice regarding The Open Offer for Shares in Ranbaxy Laboratories Limited
2008.09.02R&D
Daiichi Sankyo Announces Clinical Study Data for
Oral Factor Xa Inhibitor DU-176b
2008.08.29 Corporate
DAIICHI SANKYO Announces Cancellation of Treasury Stocks
2008.08.26Local(Japan)
DAIICHI SANKYO Notice on Organizational Restructuring
as of October 1, 2008
2008.08.25R&D
Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
2008.08.11 Corporate
DAIICHI SANKYO to Launch Open Offer for Ranbaxy Laboratories Limited
2008.08.04 Corporate
DAIICHI SANKYO Announces Results of Share Buyback
2008.07.17Other
Daiichi Sankyo and Ranbaxy confirm Deal is Binding and Final Allay market rumour and speculation
2008.07.16Local(Japan)
Asubio Pharma’s Inherited Metabolic Disease Agent Biopten®Receives Approval for Additional Indication
2008.07.16Local(Japan)
Approval Acquired for Additional Indication for the Selective Antithrombin Agents Novastan® HI Injection 10 mg/2mL and Slonnon® HI Injection 10 mg/2mL For the Inhibition of Thrombosis in Heparin-Induced Thrombocytopenia (HIT) Type II
2008.07.10Local(Japan)
Sixth Sankyo Takamine Memorial Award Announced
2008.07.09Local(Japan)
Percutaneous Absorption-type Analgesic and Anti-Inflammatory Drug Loxonin(R) Tape 50mg/100mg Launched
2008.07.09 Corporate
Luitpold Pharmaceuticals/American Regent and Fresenius Medical Care sign
agreements for exclusive sublicense of Venofer(R)in U.S.
2008.07.07Local(Japan)
DAIICHI SANKYO to Implement Carbon Offset Program
2008.06.27 Corporate
DAIICHI SANKYO to Acquire Own Shares
2008.06.24R&D
FDA Extends Review Period for Daiichi Sankyo, Lilly
Investigative Antiplatelet Drug, Prasugrel
2008.06.18Products
New Study Shows Benicar(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
2008.06.11 Corporate
Ranbaxy to bring in Daiichi Sankyo as Majority Partner
Strategic Combination creates Innovator and Generic Pharma Powerhouse
2008.06.05Products
DAIICHI SANKYO COMMENCES PATENT LITIGATION AGAINST MYLAN
AND MATRIX IN THE UNITED STATES
2008.06.02Local(Japan)
Broad-spectrum Oral Antibacterial Agent
Gracevit(R) Tablets 50mg/Fine Granules 10% Launched
2008.06.02Other
DAIICHI SANKYO Contributes to Relief Efforts for
Cyclone Nargis and Sichuan Earthquake Victims
2008.05.21 Corporate
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
2008.05.13 Corporate
Expansion of Business into Turkey and India
2008.05.13 Corporate
DAIICHI SANKYO COMPANY Announces Executive-Change Candidate
2008.05.13Products
FOREST LABORATORIES, INC. AND DAIICHI SANKYO, INC. ANNOUNCE
THE TERMINATION OF THE AZOR CO-PROMOTION AGREEMENT
2008.04.16Products
Welchol(R) Added to the American College of Endocrinology/American Association of Clinical Endocrinologists "Road Maps to Achieve Glycemic Control in Patients with Type 2 Diabetes Mellitus"
2008.03.31 Corporate
Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
2008.03.26R&D
Joint Research of Antibody Drugs with MorphoSys to be Expanded
2008.03.12Local(Japan)
The Percutaneous Absorption-Type Analgesic and Anti-inflammatory Drug Loxonin(R)Tape 50mg/100mg
Receives Approval for Manufacture and Marketing
2008.03.12R&D
Luitpold Pharmaceutical's INJECTAFER(TM)
(ferric carboxymaltose injection) receives non-approvable letter from FDA
2008.03.05 Corporate
Japanese pharmaceutical company acquires osteoporosis medication EVISTA from Lilly
DAIICHI SANKYO presses ahead with European expansion
2008.03.03Local(Japan)
DAIICHI SANKYO Notice on Organizational Restructuring as of April 1, 2008
2008.02.22R&D
FDA grants priority review for Daiichi Sankyo, Lilly drug, prasugrel
Investigational antiplatelet agent submitted for treatment of patients with acute coronary syndrome being managed with percutaneous coronary intervention
2008.02.20R&D
Daiichi Sankyo, Lilly Submit Marketing Authorization Application for
Investigational Oral Antiplatelet Drug, Prasugrel, to European
Medicines Agency
2008.02.15 Corporate
DAIICHI SANKYO Notice concerning Determination of Certain Terms of the Issue Stock Options
(Stock Acquisition Rights) as Remuneration
2008.02.04R&D
FDA Advisory Committee Supports Favorable Risk-Benefit Profile for Injectafer(TM)(Ferric Carboxymaltose Injection) Under Certain Indications for Use
2008.02.01Products
Analytical Results for Women from Large Scale Clinical Trial MEGA Study Employing the Hypercholesterolemia Drug Mevalotin(R) Published
2008.01.31IR
DAIICHI SANKYO to Issue Stock Options (Stock Acquisition Rights) as
Remuneration
2008.01.28Local(Japan)
Broad-spectrum Oral Antibacterial Agent
Gracevit(R) tablets 50mg/fine granules 10%
Receives Approval for Manufacturing and Marketing
2008.01.21R&D
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
2008.01.07R&D
Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet
Drug, Prasugrel, with U.S. Food and Drug Administration
If Approved for Marketing in the United States, Trade Name Will be Effient™
Back Number
2011
2010
2009
2008
2007
2006
2005
Browse by Category
Corporate
R&D
Products
Others